Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-03-29 Sale |
2022-03-30 6:46 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
60,000 | $38.59 | $2,315,322 | 701,899 (Indirect Direct) |
View |
2022-03-18 Sale |
2022-03-21 6:20 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
169,089 | $39.43 | $6,667,521 | 2,582,164 (Indirect Direct) |
View |
2022-02-24 Purchase |
2022-02-25 7:21 pm |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
32,500 | $37.49 | $1,218,373 | 76,136 (Indirect Direct) |
View |
2021-12-28 Sale |
2021-12-30 6:07 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
184,448 | $40.12 | $7,400,767 | 2,591,702 (Indirect Direct) |
View |
2021-11-16 Sale |
2021-11-18 7:18 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
250,000 | $42.39 | $10,596,693 | 1,593,556 (Indirect Direct) |
View |
2021-11-16 Sale |
2021-11-18 7:15 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
214,389 | $42.34 | $9,076,492 | 3,680,406 (Indirect Direct) |
View |
2021-09-28 Sale |
2021-09-30 3:56 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
128,425 | $36.51 | $4,688,288 | 3,892,800 (Indirect Direct) |
View |
2021-07-26 Sale |
2021-07-27 5:29 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
13,362 | $39.78 | $531,532 | 1,300,960 (Indirect Direct) |
View |
2021-07-26 Sale |
2021-07-27 5:25 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) |
View |
2021-07-26 Sale |
2021-07-27 5:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) |
View |
2021-07-12 Sale |
2021-07-14 5:18 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
23,149 | $42.01 | $972,456 | 1,309,409 (Indirect Direct) |
View |
2021-07-12 Sale |
2021-07-14 5:17 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
17,934 | $42.01 | $753,369 | 1,204,779 (Indirect) |
View |
2021-07-06 Sale |
2021-07-08 7:37 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
73,117 | $42.19 | $3,085,027 | 1,222,713 (Indirect) |
View |
2021-07-06 Sale |
2021-07-08 7:36 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
88,489 | $42.19 | $3,733,762 | 1,327,490 (Indirect Direct) |
View |
2021-06-25 Sale |
2021-06-29 8:31 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,314,912 | $42.11 | $55,370,134 | 6,227,558 (Indirect Direct) |
View |
2021-06-10 Sale |
2021-06-14 6:42 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
70,000 | $46.49 | $3,254,369 | 520,960 (Indirect Direct) |
View |
2021-06-04 Sale |
2021-06-08 8:15 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head of R&I |
33,134 | $46.08 | $1,526,721 | 19,020 (Indirect Direct) |
View |
2021-06-07 Sale |
2021-06-08 8:13 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
273,650 | $45.26 | $12,385,399 | 8,476,380 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-05-11 Conversion |
2022-05-11 5:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
77,000 | $0 | 294,614 (Direct) |
View |
2021-03-23 Other |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
917,322 | $0 | 36,641,176 (Indirect) |
View |
2020-06-16 Conversion |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
1,198,821 | $0 | 36,641,176 (Indirect) |
View |
2020-06-15 Option Award(A) |
2022-04-15 6:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
1,719,074 | $0 | 1,719,074 (Indirect) |
View |
Ownership(A) |
2022-04-15 6:45 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
0 | $0 | 12,106,264 (Indirect) |
View |
2022-03-31 Option Award |
2022-04-01 6:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
964 | $38.87 | 77,100 (Direct) |
View |
2022-03-31 Option Award |
2022-04-01 6:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
964 | $38.87 | 24,694 (Direct) |
View |
2022-03-17 Other |
2022-03-21 6:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,905,452 | $0 | 2,582,164 (Direct) |
View |
2021-12-31 Option Award |
2022-01-03 5:35 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
958 | $39.11 | 43,636 (Direct) |
View |
2021-12-31 Option Award |
2022-01-03 5:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
958 | $39.11 | 23,730 (Direct) |
View |
2021-12-28 Other |
2021-12-30 6:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,310,902 | $0 | 2,591,702 (Direct) |
View |
2021-09-10 Gift |
2021-12-30 6:03 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
5,128 | $0 | 481,270 (Indirect) |
View |
2021-09-10 Gift |
2021-11-18 7:18 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
1,282 | $0 | 1,593,556 (Direct) |
View |
2021-11-16 Other |
2021-11-18 7:15 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,927,363 | $0 | 3,680,406 (Direct) |
View |
2021-09-10 Gift |
2021-09-30 3:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
7,692 | $0 | 3,892,800 (Direct) |
View |
2021-09-29 Other |
2021-09-30 3:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
952,701 | $0 | 3,892,800 (Direct) |
View |
2021-09-30 Option Award |
2021-09-30 3:17 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
992 | $37.8 | 42,678 (Direct) |
View |
2021-09-30 Option Award |
2021-09-30 3:12 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
992 | $37.8 | 22,772 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
871 | $43.04 | 41,686 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 5:15 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
871 | $43.04 | 21,780 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 5:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
871 | $43.04 | 2,046,365 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
5,726 | $0 | 22,866 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:34 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
5,726 | $0 | 50,370 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
5,726 | $0 | 20,909 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
5,726 | $0 | 2,045,495 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:28 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
5,726 | $0 | 40,815 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
5,726 | $0 | 50,370 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 8:22 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
5,726 | $0 | 19,136 (Direct) |
View |